GlaxoSmithKline Intellectual Property Development Limited
发明人:
Alexis Denis,Olivier Mirguet,Jérôme Toum
申请号：
US15837297
公开号：
US20180099955A1
申请日:
2017.12.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the compound (2R,2′R)-bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) 1,1′-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis.
